VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome

Dirk Kienle, Alexander Kröber, Tiemo Katzenberger, German Ott, Elke Leupolt, Thomas F.E. Barth, Peter Möller, Axel Benner, Annett Habermann, Hans Konrad Müller-Hermelink, Martin Bentz, Peter Lichter, Hartmut Döhner, Stephan Stilgenbauer

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29% of the MCLs displayed mutated VH using a 98% germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL, ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q- and 17p- showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.

Original languageEnglish (US)
Pages (from-to)3003-3009
Number of pages7
JournalBlood
Volume102
Issue number8
DOIs
StatePublished - Oct 15 2003

Fingerprint

Mantle-Cell Lymphoma
Aberrations
Genes
Mutation
Immunoglobulins
Switches
Immunoglobulin Heavy Chain Genes
Antigens
Tetraploidy
Genetic Recombination
Survival

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Kienle, D., Kröber, A., Katzenberger, T., Ott, G., Leupolt, E., Barth, T. F. E., ... Stilgenbauer, S. (2003). VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome. Blood, 102(8), 3003-3009. https://doi.org/10.1182/blood-2003-05-1383

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma : Correlation with genomic aberrations, clinical characteristics, and outcome. / Kienle, Dirk; Kröber, Alexander; Katzenberger, Tiemo; Ott, German; Leupolt, Elke; Barth, Thomas F.E.; Möller, Peter; Benner, Axel; Habermann, Annett; Müller-Hermelink, Hans Konrad; Bentz, Martin; Lichter, Peter; Döhner, Hartmut; Stilgenbauer, Stephan.

In: Blood, Vol. 102, No. 8, 15.10.2003, p. 3003-3009.

Research output: Contribution to journalArticle

Kienle, D, Kröber, A, Katzenberger, T, Ott, G, Leupolt, E, Barth, TFE, Möller, P, Benner, A, Habermann, A, Müller-Hermelink, HK, Bentz, M, Lichter, P, Döhner, H & Stilgenbauer, S 2003, 'VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome', Blood, vol. 102, no. 8, pp. 3003-3009. https://doi.org/10.1182/blood-2003-05-1383
Kienle, Dirk ; Kröber, Alexander ; Katzenberger, Tiemo ; Ott, German ; Leupolt, Elke ; Barth, Thomas F.E. ; Möller, Peter ; Benner, Axel ; Habermann, Annett ; Müller-Hermelink, Hans Konrad ; Bentz, Martin ; Lichter, Peter ; Döhner, Hartmut ; Stilgenbauer, Stephan. / VH mutation status and VDJ rearrangement structure in mantle cell lymphoma : Correlation with genomic aberrations, clinical characteristics, and outcome. In: Blood. 2003 ; Vol. 102, No. 8. pp. 3003-3009.
@article{6860e79244b24080b1aa899c2c38286d,
title = "VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome",
abstract = "Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29{\%} of the MCLs displayed mutated VH using a 98{\%} germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL, ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q- and 17p- showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.",
author = "Dirk Kienle and Alexander Kr{\"o}ber and Tiemo Katzenberger and German Ott and Elke Leupolt and Barth, {Thomas F.E.} and Peter M{\"o}ller and Axel Benner and Annett Habermann and M{\"u}ller-Hermelink, {Hans Konrad} and Martin Bentz and Peter Lichter and Hartmut D{\"o}hner and Stephan Stilgenbauer",
year = "2003",
month = "10",
day = "15",
doi = "10.1182/blood-2003-05-1383",
language = "English (US)",
volume = "102",
pages = "3003--3009",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - VH mutation status and VDJ rearrangement structure in mantle cell lymphoma

T2 - Correlation with genomic aberrations, clinical characteristics, and outcome

AU - Kienle, Dirk

AU - Kröber, Alexander

AU - Katzenberger, Tiemo

AU - Ott, German

AU - Leupolt, Elke

AU - Barth, Thomas F.E.

AU - Möller, Peter

AU - Benner, Axel

AU - Habermann, Annett

AU - Müller-Hermelink, Hans Konrad

AU - Bentz, Martin

AU - Lichter, Peter

AU - Döhner, Hartmut

AU - Stilgenbauer, Stephan

PY - 2003/10/15

Y1 - 2003/10/15

N2 - Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29% of the MCLs displayed mutated VH using a 98% germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL, ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q- and 17p- showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.

AB - Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29% of the MCLs displayed mutated VH using a 98% germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL, ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q- and 17p- showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.

UR - http://www.scopus.com/inward/record.url?scp=0141889260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141889260&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-05-1383

DO - 10.1182/blood-2003-05-1383

M3 - Article

C2 - 12842981

AN - SCOPUS:0141889260

VL - 102

SP - 3003

EP - 3009

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -